1078 related articles for article (PubMed ID: 11325641)
1. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
[TBL] [Abstract][Full Text] [Related]
2. Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients.
Thiele J; Kvasnicka HM; Muehlhausen K; Walter S; Zankovich R; Diehl V
Pathol Res Pract; 2001; 197(2):77-84. PubMed ID: 11261821
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow features of diagnostic impact in erythrocytosis.
Thiele J; Kvasnicka HM; Diehl V
Ann Hematol; 2005 Jun; 84(6):362-7. PubMed ID: 15803315
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of polycythemia vera based on bone marrow pathology.
Thiele JM; Kvasnicka HM
Curr Hematol Rep; 2005 May; 4(3):218-23. PubMed ID: 15865875
[TBL] [Abstract][Full Text] [Related]
5. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
6. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
Mossuz P; Girodon F; Donnard M; Latger-Cannard V; Dobo I; Boiret N; Lecron JC; Binquet C; Barro C; Hermouet S; Praloran V
Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV).
Thiele J; Kvasnicka HM
Histol Histopathol; 2005 Jan; 20(1):317-28. PubMed ID: 15578448
[TBL] [Abstract][Full Text] [Related]
9. [ Polyglobuly versus polycythemia vera].
Thiele J; Kvasnicka HM
Pathologe; 2000 Jan; 21(1):24-30. PubMed ID: 10663666
[TBL] [Abstract][Full Text] [Related]
10. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
[TBL] [Abstract][Full Text] [Related]
11. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
Ellis JT; Peterson P; Geller SA; Rappaport H
Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
[TBL] [Abstract][Full Text] [Related]
12. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
[TBL] [Abstract][Full Text] [Related]
13. Endogenous erythroid colony assay in patients with polycythemia vera and its clinical significance.
Bai J; Shao ZH; Liu H; Shi J; He GS; Cao YR; Cui ZZ; Wu YH; Sun J; Tian Z; Jia HR; Qian LS; Yang TY; Yang CL
Chin Med J (Engl); 2004 May; 117(5):668-72. PubMed ID: 15161531
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow morphologic features in polycythemia vera with JAK2 exon 12 mutations.
Lakey MA; Pardanani A; Hoyer JD; Nguyen PL; Lasho TL; Tefferi A; Hanson CA
Am J Clin Pathol; 2010 Jun; 133(6):942-8. PubMed ID: 20472853
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of the assessment of erythroid progenitors growth for differential diagnosis of primary and secondary polycythemias.
Hansz J; Kozłowska-Skrzypczak M; Mencel P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):630-7. PubMed ID: 2448202
[TBL] [Abstract][Full Text] [Related]
16. [A clinical and biological study of 33 cases of polycythemia vera].
Corredoira JC; González M; Pérez R; Casariego E; López MJ; García JF; Arias J
Rev Clin Esp; 1990 May; 186(8):378-82. PubMed ID: 2236766
[TBL] [Abstract][Full Text] [Related]
17. Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?
Thiele J; Kvasnicka HM
Curr Hematol Malig Rep; 2006 Jun; 1(2):87-92. PubMed ID: 20425337
[TBL] [Abstract][Full Text] [Related]
18. The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia.
Gianelli U; Iurlo A; Vener C; Moro A; Fermo E; Bianchi P; Graziani D; Radaelli F; Coggi G; Bosari S; Deliliers GL; Zanella A
Am J Clin Pathol; 2008 Sep; 130(3):336-42. PubMed ID: 18701405
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
20. Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study.
Remacha AF; Montserrat I; Santamaria A; Oliver A; Barceló MJ; Parellada M
Haematologica; 1997; 82(4):406-10. PubMed ID: 9299851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]